News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Advertise
Talent Solutions
Post Jobs
Submit a Press Release
Submit an Event
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Advertise
Talent Solutions
Post Jobs
Submit a Press Release
Submit an Event
Search Query
Submit Search
News
Business
Alexion Pharmaceuticals Inc. Reports Fourth Quarter and Full Year 2008 Results
February 12, 2009
|
1 min read
Twitter
LinkedIn
Facebook
Email
Print
CHESHIRE, Conn.--(BUSINESS WIRE)--Alexion Pharmaceuticals, Inc. (NASDAQ: ALXN): 2008 and Fourth Quarter Financial Highlights:
Twitter
LinkedIn
Facebook
Email
Print
Earnings
Alexion
MORE ON THIS TOPIC
Business
Genentech culls 103 jobs, inks $490M-plus biobucks deal with Astex
July 6, 2026
·
2 min read
·
Gabrielle Masson
Layoff Tracker
Genentech, BioNTech cut over 100 roles each
July 6, 2026
·
66 min read
·
BioSpace Editorial Staff
IPO
Early-stage Scribe wants to write IPO story even as investors favor derisked portfolios
July 6, 2026
·
2 min read
·
Tristan Manalac
China
AstraZeneca taps China’s CSPC again, betting up to $1.77B to target kidney diseases
July 2, 2026
·
2 min read
·
Tristan Manalac
